|
US6861053B1
(en)
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
|
US7048906B2
(en)
|
1995-05-17 |
2006-05-23 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
|
|
US7078399B2
(en)
*
|
2001-12-13 |
2006-07-18 |
Activbiotics, Inc. |
Sulfhydryl rifamycins and uses thereof
|
|
ITMI20032144A1
(it)
*
|
2003-11-07 |
2005-05-08 |
Alfa Wassermann Spa |
Forme polimorfe di rifaximina, processi per ottenerle e
|
|
US7923553B2
(en)
|
2003-11-07 |
2011-04-12 |
Alfa Wassermann, S.P.A. |
Processes for the production of polymorphic forms of rifaximin
|
|
US7902206B2
(en)
|
2003-11-07 |
2011-03-08 |
Alfa Wassermann, S.P.A. |
Polymorphic forms α, β and γ of rifaximin
|
|
US20080262024A1
(en)
*
|
2003-11-07 |
2008-10-23 |
Giuseppe Claudio Viscomi |
Rifaximin compositions and method of use
|
|
US7906542B2
(en)
|
2004-11-04 |
2011-03-15 |
Alfa Wassermann, S.P.A. |
Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
|
|
US20060210483A1
(en)
*
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
|
|
US8003118B2
(en)
*
|
2005-03-02 |
2011-08-23 |
Kodsi Robert E |
Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
|
|
US20060210492A1
(en)
*
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Use of rifaximin for treatment and prevention of periodontal conditions
|
|
EP1698630B1
(en)
*
|
2005-03-03 |
2014-09-03 |
ALFA WASSERMANN S.p.A. |
New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
|
|
ITBO20050123A1
(it)
|
2005-03-07 |
2005-06-06 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
|
|
DK1996710T3
(da)
|
2006-03-09 |
2019-10-07 |
Salix Pharmaceuticals Inc |
Rifaximin-præparat mod rektal dysfunktion
|
|
JP5844961B2
(ja)
|
2006-08-02 |
2016-01-20 |
サリックス ファーマシューティカルズ， インコーポレイテッド |
放射線直腸ｓ状結腸炎を処置するための組成物および方法
|
|
ITMI20061692A1
(it)
|
2006-09-05 |
2008-03-06 |
Alfa Wassermann Spa |
Uso di polioli per ottenere forme polimorfe stabili di rifaximina
|
|
AU2007298733B2
(en)
*
|
2006-09-22 |
2012-11-08 |
Cipla Limited |
Rifaximin
|
|
US20080161337A1
(en)
*
|
2007-01-03 |
2008-07-03 |
Leonard Weinstock |
Use of Rifaximin for the Treatment of Chronic Prostatitis
|
|
US20080159987A1
(en)
*
|
2007-01-03 |
2008-07-03 |
Leonard Weinstock |
Use of Rifaximin for the Treatment of Restless Legs Syndrome
|
|
ITMI20071241A1
(it)
*
|
2007-06-20 |
2008-12-21 |
Solmag S P A |
Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
|
|
US7709634B2
(en)
|
2007-09-20 |
2010-05-04 |
Apotex Pharmachem Inc. |
Amorphous form of rifaximin and processes for its preparation
|
|
US8486956B2
(en)
|
2008-02-25 |
2013-07-16 |
Salix Pharmaceuticals, Ltd |
Forms of rifaximin and uses thereof
|
|
CN104650114A
(zh)
|
2008-02-25 |
2015-05-27 |
萨利克斯药品有限公司 |
利福昔明的多种形式及其用途
|
|
PT2252148T
(pt)
|
2008-02-26 |
2020-01-23 |
Salix Pharmaceuticals Ltd |
Métodos de tratamento da síndrome do intestino irritável
|
|
US11779571B2
(en)
|
2008-02-26 |
2023-10-10 |
Salix Pharmaceuticals, Inc. |
Methods for treating irritable bowel syndrome (IBS)
|
|
EP2294012B1
(en)
|
2008-05-07 |
2014-07-09 |
Salix Pharmaceuticals, Ltd. |
Administration of a bowel cleanser and an antibiotic for the treatment of bowel disease
|
|
CN101585843B
(zh)
*
|
2008-05-21 |
2011-07-06 |
重庆赛诺生物药业股份有限公司 |
一种利福昔明的制备工艺
|
|
US7928115B2
(en)
*
|
2008-10-02 |
2011-04-19 |
Salix Pharmaceuticals, Ltd. |
Methods of treating travelers diarrhea and hepatic encephalopathy
|
|
US20110035232A1
(en)
*
|
2008-10-02 |
2011-02-10 |
Salix Pharmaceuticals, Ltd. |
Methods of treating hepatic encephalopathy
|
|
PT3628319T
(pt)
|
2008-10-02 |
2024-03-22 |
Salix Pharmaceuticals Ltd |
Tratamento da encefalopatia hepática com rifaximina
|
|
US12285414B2
(en)
|
2008-10-02 |
2025-04-29 |
Salix Pharmaceuticals, Inc. |
Methods of treating hepatic encephalopathy
|
|
EP2355805B1
(en)
|
2008-12-10 |
2019-02-13 |
Cipla Limited |
Rifaximin complexes
|
|
IT1397617B1
(it)
|
2009-04-20 |
2013-01-18 |
Alfa Wassermann Spa |
Nuovi derivati della rifamicina
|
|
RU2540513C2
(ru)
|
2009-06-02 |
2015-02-10 |
Саликс Фармасьютикалз, Лтд. |
Способы лечения печеночной энцефалопатии
|
|
RU2582940C2
(ru)
|
2009-09-13 |
2016-04-27 |
Саликс Фармасьютикалз, Лтд. |
Способы лечения синдрома раздраженного кишечника (срк)
|
|
RU2012126084A
(ru)
|
2009-11-23 |
2013-12-27 |
Сипла Лимитед |
Пенная композиция для местного применения
|
|
EP2401282B2
(en)
|
2009-12-28 |
2017-01-04 |
Silvio Massimo Lavagna |
Method for the production of amorphous rifaximin
|
|
JP5896380B2
(ja)
|
2010-02-18 |
2016-03-30 |
サリックス ファーマスーティカルズ，リミテッド |
感染症を治療するための方法
|
|
IT1398550B1
(it)
|
2010-03-05 |
2013-03-01 |
Alfa Wassermann Spa |
Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
|
|
WO2011156897A2
(en)
*
|
2010-06-16 |
2011-12-22 |
Apotex Pharmachem Inc. |
Polymorphic forms of rifaximin
|
|
SMT202000390T1
(it)
|
2010-07-12 |
2020-09-10 |
Salix Pharmaceuticals Inc |
Formulazioni di rifaximina e loro usi
|
|
US8759513B2
(en)
|
2010-09-13 |
2014-06-24 |
Sequent Scientific Limited |
Polymorphic form of rifaximin and process for its preparation
|
|
AU2012214239B2
(en)
|
2011-02-11 |
2016-06-30 |
Salix Pharmaceuticals, Ltd. |
Forms of Rifaximin and uses thereof
|
|
EP2705042A1
(en)
|
2011-05-02 |
2014-03-12 |
Ranbaxy Laboratories Limited |
Rifaximin dimethylformamide solvate
|
|
WO2012155981A1
(en)
|
2011-05-19 |
2012-11-22 |
Friulchem Spa |
New process for the synthesis of rifaximin and a new pseudo-crystalline form of rifaximin obtained thereby
|
|
ITBO20110461A1
(it)
|
2011-07-29 |
2013-01-30 |
Alfa Wassermann Spa |
Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
|
|
CA2854380A1
(en)
|
2011-11-02 |
2013-05-10 |
Salix Pharmaceuticals, Ltd. |
Methods for treating irritable bowel syndrome (ibs) and infections
|
|
US9359374B2
(en)
|
2012-06-13 |
2016-06-07 |
Apotex Pharmachem Inc. |
Polymorphic forms of rifaximin
|
|
ITBO20120368A1
(it)
|
2012-07-06 |
2014-01-07 |
Alfa Wassermann Spa |
Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
|
|
EP2968283A1
(en)
|
2013-03-15 |
2016-01-20 |
ALFA WASSERMANN S.p.A. |
Rifaximin for use in the treating of vaginal infections.
|
|
JP2016516988A
(ja)
|
2013-03-15 |
2016-06-09 |
アルファ ワッセルマン ソシエタ ペル アチオニＡｌｆａ Ｗａｓｓｅｒｍａｎｎ Ｓ．Ｐ．Ａ． |
膣感染症を診断するための方法
|
|
EP2983647B1
(en)
|
2013-04-12 |
2020-09-09 |
Alfasigma S.p.A. |
Nsaid administration and related compositions, methods and systems
|
|
US9018225B1
(en)
|
2013-07-26 |
2015-04-28 |
Novel Laboratories |
Rifaximin crystalline forms and methods of preparation thereof
|
|
ITMI20131307A1
(it)
|
2013-08-02 |
2015-02-02 |
A M S A Anonima Materie Sint & Affini S P A |
Processo per la preparazione di refaximina k
|
|
CN103509038B
(zh)
*
|
2013-09-30 |
2016-01-20 |
浙江思贤制药有限公司 |
一种新晶型利福昔明ζ及其制备方法
|
|
EP2927235B1
(en)
|
2014-03-31 |
2017-02-08 |
Euticals S.P.A. |
Polymorphic mixture of rifaximin and its use for the preparation of solid formulations
|
|
MX375805B
(es)
|
2014-05-04 |
2025-03-07 |
Salix Pharmaceuticals Inc |
Microbiota ibs y sus usos.
|
|
SI3143027T1
(sl)
|
2014-05-12 |
2019-10-30 |
Alfasigma Spa |
Nova solvatirana kristalna oblika rifaksimina, proizvodnja, sestavki in uporaba le-teh
|
|
EP2982764A1
(en)
|
2014-08-05 |
2016-02-10 |
ALFA WASSERMANN S.p.A. |
Identification of vaginal bacteria
|
|
US9988398B2
(en)
|
2016-06-07 |
2018-06-05 |
Cadila Healthcare Limited |
Crystalline form of rifaximin and process for its preparation
|
|
KR20240124428A
(ko)
|
2016-09-30 |
2024-08-16 |
샐릭스 파마슈티컬스 인코포레이티드 |
리팍시민의 고체 분산물 형태
|
|
WO2019003076A1
(en)
*
|
2017-06-26 |
2019-01-03 |
Biofer S.P.A. |
PYRIDO-IMIDAZO-RIFAMYCIN DERIVATIVES AS ANTIBACTERIAL AGENT
|